Independent validation by deep-targeted sequencing of a 1.6 Mb region flanking SOX2 in tumor-normal tissue pairs of 16 additional patients with HGSOCs identified two further mutations in the BB5 region in two patients. The gene discussed is SOX2; the disease is neoplasm.